ClearPoint Neuro (CLPT)
(Delayed Data from NSDQ)
$10.81 USD
-0.40 (-3.57%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $10.82 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CLPT 10.81 -0.40(-3.57%)
Will CLPT be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for CLPT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLPT
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Tops Revenue Estimates
Orthofix (OFIX) Surpasses Q2 Earnings and Revenue Estimates
CLPT: What are Zacks experts saying now?
Zacks Private Portfolio Services
ClearPoint Neuro, Inc. (CLPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Strength Seen in ClearPoint Neuro (CLPT): Can Its 16.9% Jump Turn into More Strength?
ClearPoint's (CLPT) New Products to Boost Neurosurgical Segment
Other News for CLPT
ClearPoint Neuro Inc (CLPT) Shares Gap Down to $11.65 on Sep 23
Hain Celestial Posts Upbeat Q4 Earnings, Joins Soleno Therapeutics, Energizer Holdings And Other Big Stocks Moving Higher On Tuesday
Lake Street Sticks to Their Buy Rating for ClearPoint Neuro (CLPT)
Lake Street Reaffirms Their Buy Rating on ClearPoint Neuro (CLPT)
ClearPoint Neuro price target raised by $4 at Lake Street, here's why